In 1961 the National Cancer Institute initiated a program to conduct bioassays of selected compounds to determine whether they might be carcinogens. Although some similarities continue with the program as it was in 1961, there are many more differences. Since 1985 when the first edition of this book appeared, these differences have been substantial enough to merit an updated version. This updated edition will provide the reader with an overview of how to proceed with the various tests and how the data are eventually used for regulatory decisions.
Auflage
Sprache
Verlagsort
Zielgruppe
Für Beruf und Forschung
Policymakers on the federal, state, and local levels in regards to legislating on carcinogens.
Editions-Typ
Maße
Höhe: 229 mm
Breite: 152 mm
Gewicht
ISBN-13
978-0-8155-1356-8 (9780815513568)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
Autor*in
National Cancer Institute, USA
National Cancer Institute, USA
Part I. Predicting Carcinogenicity of Chemicals from Their StructurePart II. Epidemiological InvestigationsPart III. In Vitro TestsPart IV. Limited BioassaysPart V. Long-Term Animal BioassaysPart VI. Bioassays for Insoluble MaterialsPart VII. Assays with Potential UtilityPart VIII. Risk EstimationPart IX. Regulatory ImplicationsPart X. Industry PerspectiveIndex